AngelMD has put an undisclosed amount into Otomagnetics, a developer of a magnetic injection delivery system based on research at University of Maryland, College Park.
Otomagnetics, a US-based drug delivery technology developer spun out from University of Maryland, College Park, has raised an undisclosed sum from an angel syndicate through investment platform AngelMD.
Founded in 2012, Otomagnetics is working on a needle-less, magnetic injection delivery technology that offers an effective way of delivering drugs, genes or proteins through tissue to challenging locations such as the eye or the ear.
The approach is based on research undertaken by Benjamin Shapiro, full professor at the Fischell Department…
